LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA – Eli Lilly and Company Transaction History
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA portfolio value:
$1.38M
portfolio value
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +8.88% | 350 shares | 110K | $323.35 | 4.29K |
| Q2 2022 | share | Increase | +2.42% | 93 shares | 175K | $324.23 | 3.94K |
| Q1 2022 | share | Increase | +3.72% | 138 shares | 78K | $286.37 | 3.85K |
| Q4 2021 | share | Decrease | -1.20% | -45 shares | 157K | $277.25 | 3.71K |
| Q3 2021 | share | Increase | +1.54% | 57 shares | 19K | $230.3 | 3.75K |
| Q2 2021 | share | Decrease | -1.39% | -52 shares | 148K | $228.04 | 3.7K |
| Q1 2021 | share | Increase | +2.23% | 82 shares | 81K | $184.81 | 3.75K |
| Q4 2020 | share | 0.00% | 0 shares | 77K | $166.32 | 3.67K | |
| Q3 2020 | share | 0.00% | 0 shares | -60K | $145.05 | 3.67K | |
| Q2 2020 | share | Decrease | -17.25% | -765 shares | -12K | $160.1 | 3.67K |
| Q1 2020 | share | Decrease | -5.13% | -240 shares | 1K | $134.64 | 4.43K |
| Q4 2019 | share | Decrease | -2.01% | -96 shares | 80K | $126.91 | 4.67K |
| Q3 2019 | share | Decrease | -0.40% | -19 shares | 3K | $107.36 | 4.77K |
| Q2 2019 | share | Increase | +5.39% | 245 shares | -59K | $105.74 | 4.79K |
| Q1 2019 | share | Increase | +3.30% | 145 shares | 81K | $123.17 | 4.54K |
| Q4 2018 | share | 0.00% | 0 shares | 37K | $109.26 | 4.4K | |
| Q3 2018 | share | 0.00% | 0 shares | 97K | $100.8 | 4.4K | |
| Q2 2018 | share | 0.00% | 0 shares | 35K | $79.72 | 4.4K | |
| Q1 2018 | share | 0.00% | 0 shares | -32K | $71.78 | 4.4K | |
| Q4 2017 | share | Decrease | -1.03% | -46 shares | -8K | $77.79 | 4.4K |
| Q3 2017 | share | Increase | +1.05% | 46 shares | 16K | $78.29 | 4.44K |
| Q2 2017 | share | Decrease | -4.35% | -200 shares | -23K | $74.85 | 4.4K |
| Q1 2017 | share | Increase | +4.55% | 200 shares | 63K | $76 | 4.6K |
| Q4 2016 | share | 0.00% | 0 shares | -29K | $66.02 | 4.4K | |
| Q3 2016 | share | 0.00% | 0 shares | 6K | $71.57 | 4.4K | |
| Q2 2016 | share | Increase | +388.89% | 3.5K shares | 282K | $69.79 | 4.4K |
| Q1 2016 | share | 0.00% | 0 shares | -11K | $63.39 | 900 |